UK biotech raises bumper $2 billion, despite Brexit blues


Britain's biotechnology industry has raised a bumper 1.56 billion pounds in the first eight months of this year, surpassing the 1.2 billion reached in the whole of 2017, despite anxiety in the sector about the fallout from Brexit. The increase has been fueled by recent changes to venture capital tax incentives, according to UK BioIndustry Association CEO Steve Bates, as well as global investor enthusiasm for drug discoveries emanating from biotech labs.



from Biotech News